Dr Reddy’s Laboratories to launch pain relief spray in India

Published On 2015-11-03 05:17 GMT   |   Update On 2015-11-03 05:17 GMT
Advertisement
Dr Reddy's Laboratories is reported to have introduced a pain relief spray under 'Nise D Spray' in the Indian market. This initiative can be viewed as a part of its efforts to increase its presence across the Indian over-the-counter (OTC) market.

With the entry in this new healthcare product vertical, Dr Reddy’s Laborataries is targeting to grab a share of the massive pain relief products in India, estimated to be around Rs 1700 crore.

To be made available in a pocket pack size priced at Rs 99, the spray will also come in an additional home pack for Rs 130, as confirmed the by the company in a press statement. Nise D spray offers quick and targeted pain killing, the company said.

Dr Reddy's EVP and Head Branded Markets (India & Emerging countries) MV Ramana said: "Nise D Spray marks our entry into the new segment and further boosts our OTC portfolio."

Dr Reddy's said that as per A C Nielsen Retail Measurement Study MAT August 2015, the market for pain relief products in India is approximately Rs 1,700 crore.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News